Professor Adrienne M Flanagan
Professor Adrienne M Flanagan
Head of Pathology, UCL
Verified email at
Cited by
Cited by
Mutations of the BRAF gene in human cancer
H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg, J Teague, ...
Nature 417 (6892), 949-954, 2002
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
PJ Stephens, CD Greenman, B Fu, F Yang, GR Bignell, LJ Mudie, ...
cell 144 (1), 27-40, 2011
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford, E Dawson, S Forbes, J Clements, R Pettett, A Dogan, ...
British journal of cancer 91 (2), 355-358, 2004
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
MF Amary, K Bacsi, F Maggiani, S Damato, D Halai, F Berisha, R Pollock, ...
The Journal of pathology 224 (3), 334-343, 2011
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study
W Bartlett, JA Skinner, CR Gooding, RWJ Carrington, AM Flanagan, ...
The Journal of Bone & Joint Surgery British Volume 87 (5), 640-645, 2005
Intragenic ERBB2 kinase mutations in tumours
P Stephens, C Hunter, G Bignell, S Edkins, H Davies, J Teague, ...
Nature 431 (7008), 525-526, 2004
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
S Behjati, PS Tarpey, N Presneau, S Scheipl, N Pillay, P Van Loo, ...
Nature genetics 45 (12), 1479-1482, 2013
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
S Vujovic, S Henderson, N Presneau, E Odell, TS Jacques, R Tirabosco, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
Somatic mutations of the protein kinase gene family in human lung cancer
H Davies, C Hunter, R Smith, P Stephens, C Greenman, G Bignell, ...
Cancer research 65 (17), 7591-7595, 2005
Mammary and extramammary Paget's disease
J Lloyd, AM Flanagan
Journal of clinical pathology 53 (10), 742-749, 2000
Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma
HW Wang, MWB Trotter, D Lagos, D Bourboulia, S Henderson, T Mäkinen, ...
Nature genetics 36 (7), 687-693, 2004
The advantages of targeted protein degradation over inhibition: an RTK case study
GM Burslem, BE Smith, AC Lai, S Jaime-Figueroa, DC McQuaid, ...
Cell chemical biology 25 (1), 67-77. e3, 2018
S Forbes, J Clements, E Dawson, S Bamford, T Webb, A Dogan, ...
British journal of cancer 94 (2), 318-322, 2006
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
MF Amary, S Damato, D Halai, M Eskandarpour, F Berisha, F Bonar, ...
Nature genetics 43 (12), 1262-1265, 2011
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ...
European journal of cancer 109, 36-50, 2019
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 1251343, 2014
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer
P Stephens, S Edkins, H Davies, C Greenman, C Cox, C Hunter, G Bignell, ...
Nature genetics 37 (6), 590-592, 2005
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
YS Ju, LB Alexandrov, M Gerstung, I Martincorena, S Nik-Zainal, ...
elife 3, e02935, 2014
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
SR Lakhani, S Manek, F Penault-Llorca, A Flanagan, L Arnout, S Merrett, ...
Clinical Cancer Research 10 (7), 2473-2481, 2004
The system can't perform the operation now. Try again later.
Articles 1–20